After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Drug Manufacturers – Specialty & Generic industry segment, falling under the Healthcare sector. The current market capitalization of Esperion Therapeutics Inc is $263.61M. A total of 5.55 million shares were traded on the day, compared to an average of 4.39M shares.
In the most recent transaction, Looker Benjamin sold 1,304 shares of ESPR for 1.13 per share on Jul 17 ’25. After the transaction, the General Counsel now owns 399,937 company shares. In a previous transaction on Jul 17 ’25, Halladay Benjamin sold 11 shares at 1.11 per share. ESPR shares that Chief Financial Officer owns now total 474,462.
Among the insiders who bought shares, Looker Benjamin acquired of 1,304 shares on Jul 17 ’25 at a per-share price of $1.13. In another insider transaction, Halladay Benjamin bought 11 shares at $1.12 per share on Jul 17 ’25.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, ESPR has a high of $3.94 and a low of $0.69.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. ESPR’s latest balance sheet shows that the firm has $259.33M in Cash & Short Term Investments as of fiscal 2021. There were $260.20M in debt and $73.35M in liabilities at the time. Its Book Value Per Share was $-2.17, while its Total Shareholder’s Equity was $-196.94M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ESPR is Buy with a score of 4.00.
